U.S. regulators say J&J's single-dose vaccine protects against COVID-19. The report says overall the vaccine is about 66% effective at preventing moderate to severe COVID. This sets the stage for a final decision on FDA emergency use. (Feb. 24)

Subscribe for more Breaking News: http://smarturl.it/AssociatedPress
Website: https://apnews.com
Twitter: https://twitter.com/AP
Facebook: https://facebook.com/APNews
Google+: https://plus.google.com/115892241801867723374
Instagram: https://www.instagram.com/APNews/
​

You can license this story through AP Archive: http://www.aparchive.com/metadata/youtube/a8109b744c7845beb2c24ca28544afb1